| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Complement-mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 antibodies
|
Olafsen, Tove
|
|
1999
|
48 |
7 |
p. 411-418
|
artikel
|
| 2 |
Effective cancer therapy with a single injection of interleukin-2 at the site of the tumour
|
Otter, Willem Den
|
|
1999
|
48 |
7 |
p. 419-420
|
artikel
|
| 3 |
Function and dysfunction of CD4+ T cells in the immune response to melanoma
|
Fischer, Wolfgang H.
|
|
1999
|
48 |
7 |
p. 363-370
|
artikel
|
| 4 |
HER-2/neu peptide specificity in the recognition of HLA-A2 by natural killer cells
|
Anderson Jr., Larry D.
|
|
1999
|
48 |
7 |
p. 401-410
|
artikel
|
| 5 |
How tumors escape immune destruction and what we can do about it
|
Gilboa, Eli
|
|
1999
|
48 |
7 |
p. 382-385
|
artikel
|
| 6 |
How tumors escape immune destruction and what we can do about it
|
Gilboa, Eli
|
|
|
48 |
7 |
p. 382-385
|
artikel
|
| 7 |
In situ T cells in melanoma
|
thor Straten, Per
|
|
1999
|
48 |
7 |
p. 386-395
|
artikel
|
| 8 |
Selective MHC expression in tumours modulates adaptive and innate antitumour responses
|
Rees, Robert C.
|
|
1999
|
48 |
7 |
p. 374-381
|
artikel
|
| 9 |
Signaling defects in T lymphocytes of patients with malignancy
|
Whiteside, Theresa L.
|
|
1999
|
48 |
7 |
p. 346-352
|
artikel
|
| 10 |
Targeting unique tumor antigens and modulating the cytokine environment may improve immunotherapy for tumors with immune escape mechanisms
|
Slingluff, Craig L.
|
|
1999
|
48 |
7 |
p. 371-373
|
artikel
|
| 11 |
Tumor-induced immune dysfunction
|
Kiessling, Rolf
|
|
1999
|
48 |
7 |
p. 353-362
|
artikel
|
| 12 |
Tumour escape from the immune response: the last hurdle for successful immunotherapy of cancer?
|
Pawelec, Graham
|
|
1999
|
48 |
7 |
p. 343-345
|
artikel
|
| 13 |
Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer
|
Yanagawa, Hiroaki
|
|
1999
|
48 |
7 |
p. 396-400
|
artikel
|
Tijdschrift beschrijving